Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cellsway logo — Liquid biopsy for cancer monitoring through isolation and co...

Cellsway

Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells (CTCs) from blood.

Founded 2020 United Kingdom Ankara, United Kingdom 5 employees Unknown Total: $1.45M Biotechnology, Health Care

General Information

Company Name Cellsway
Founded Year 2020
Location United Kingdom Ankara, United Kingdom +1
Founders / Decision Makers
Team member
Employees 5
Industries Biotechnology, Health Care
Funding Stage Unknown
Social

Get notified when Cellsway moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellsway

Cellsway, a deep-tech start-up, is making strides in the Biotechnology and Health Care industries with its innovative approach to cancer monitoring. Founded in 2020 in the United Kingdom, this company aims to revolutionize cancer diagnostics through its flagship product: a liquid biopsy platform.

The company's technology focuses on isolating and counting Circulating Tumor Cells (CTCs) using patent-pending microfluidic technology. By utilizing a simple blood sample, it offers a non-invasive method for cancer diagnostics and research, setting a new standard in the field.

Most recently, Cellsway secured a €1.00M early VC investment on 01 August 2024 from the Turkish Development Fund, signifying strong investor confidence in their potential. This financial backing supports their mission to transform cutting-edge technology into commercial solutions, potentially reshaping how cancer is diagnosed and managed globally.

Taxonomy: Liquid Biopsy, Cancer Monitoring, Circulating Tumor Cells, CTC Detection, Microfluidics, Lab-on-a-chip, Biomedical Technology, Cancer Diagnostics, Cancer Research, Minimally Invasive Technology, Blood Sample Analysis, Deep-tech Startup, Oncology, Precision Medicine, Patent-pending Technology

Services & Products

CTC Enrichment Device
CTC Identification Panel
ER/PR/Her2 CTC Panel
PD-L1 CTC Panel

Target Customers

Cancer Patients Oncologists Clinical Laboratories Research Institutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• 1 •••• •••• 01 Aug 2024
Grant •••••• 1
Investor
01 Oct 2023
Convertible Note •••••• - 01 Jul 2023
Convertible Note •••••• 1
Investor
01 Aug 2022
Convertible Note •••••• 1
Investor
01 Dec 2021

Latest News

View All
Sağlık teknolojileri geliştiren Cellsway, APY Ventures’tan 200 bin euro yatırım aldı — Webrazzi
Sağlık teknolojileri geliştiren Cellsway, APY Ventures’tan 200 bin euro yatırım aldı
Webrazzi Jan 23, 2024
Sağlık teknolojilerine odaklanan Cellsway, Teknoloji ve İnovasyon Fonu'ndan yatırım aldı — Webrazzi
Sağlık teknolojilerine odaklanan Cellsway, Teknoloji ve İnovasyon Fonu'ndan yatırım aldı
Webrazzi Aug 22, 2024

Cellsway Alternatives & Competitors

View All Alternatives
Cellsway vs
Onco Filtration, Inc.
Onco Filtration, Inc. United States

Onco Filtration has developed a fully patented, proprietary technology to fundamentally revolutioniz...

6 employees
Cellsway vs
Vortex Biosciences
Vortex Biosciences United States

Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have...

Series Unknown
7 employees
Biotechnology, Health Care
Cellsway vs
Adela, Inc.
Adela, Inc. United States

Advancing the field of epigenomics to transform how cancer is detected and monitored.

Unknown
70 employees
Biotechnology, Pharmaceutical
Also compare with: Cellsway vs Exosome Diagnostics, a Bio-Techne brand Exosome Diagnostics, a Bio-Techne brand View all alternatives

FAQ About Cellsway

Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells (CTCs) from blood.
Cellsway was founded in 2020.
Cellsway is headquartered in Ankara, United Kingdom.
Cellsway operates in the following industries: Biotechnology, Health Care.
Cellsway has approximately 5 employees.
Cellsway has completed 5 funding rounds, raising a total of $1.45M. The latest funding stage is Unknown.
Cellsway offers: CTC Enrichment Device, CTC Identification Panel, ER/PR/Her2 CTC Panel, PD-L1 CTC Panel.
Top alternatives and competitors to Cellsway include Onco Filtration, Inc., Vortex Biosciences, Adela, Inc., JaxBio, Navaux. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellsway and Onco Filtration, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellsway and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy